Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.

Acute pancreatitis (AP), especially severe acute pancreatitis often causes extra-pancreatic complications, such as acute gastrointestinal mucosal lesion (AGML) which is accompanied by a considerably high mortality, yet the pathogenesis of AP-induced AGML is still not fully understood. In this report...

Full description

Bibliographic Details
Main Authors: Ming-hua Cao, Yong-yu Li, Jing Xu, Ya-jing Feng, Xu-hong Lin, Kun Li, Tong Han, Chang-jie Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3532296?pdf=render
id doaj-a67c648334814c80a91a8bcec93ff21b
record_format Article
spelling doaj-a67c648334814c80a91a8bcec93ff21b2020-11-24T21:44:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5292110.1371/journal.pone.0052921Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.Ming-hua CaoYong-yu LiJing XuYa-jing FengXu-hong LinKun LiTong HanChang-jie ChenAcute pancreatitis (AP), especially severe acute pancreatitis often causes extra-pancreatic complications, such as acute gastrointestinal mucosal lesion (AGML) which is accompanied by a considerably high mortality, yet the pathogenesis of AP-induced AGML is still not fully understood. In this report, we investigated the alterations of serum components and gastric endocrine and exocrine functions in rats with experimental acute pancreatitis, and studied the possible contributions of these alterations in the pathogenesis of AGML. In addition, we explored the intervention effects of cannabinoid receptor agonist HU210 and antagonist AM251 on isolated and serum-perfused rat stomach. Our results showed that the AGML occurred after 5 h of AP replication, and the body homeostasis was disturbed in AP rat, with increased levels of pancreatic enzymes, lipopolysaccharide (LPS), proinflammtory cytokines and chemokines in the blood, and an imbalance of the gastric secretion function. Perfusing the isolated rat stomach with the AP rat serum caused morphological changes in the stomach, accompanied with a significant increment of pepsin and [H+] release, and increased gastrin and decreased somatostatin secretion. HU210 reversed the AP-serum-induced rat pathological alterations, including the reversal of transformation of the gastric morphology to certain degree. The results from this study prove that the inflammatory responses and the imbalance of the gastric secretion during the development of AP are responsible for the pathogenesis of AGML, and suggest the therapeutic potential of HU210 for AGML associated with acute pancreatitis.http://europepmc.org/articles/PMC3532296?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ming-hua Cao
Yong-yu Li
Jing Xu
Ya-jing Feng
Xu-hong Lin
Kun Li
Tong Han
Chang-jie Chen
spellingShingle Ming-hua Cao
Yong-yu Li
Jing Xu
Ya-jing Feng
Xu-hong Lin
Kun Li
Tong Han
Chang-jie Chen
Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
PLoS ONE
author_facet Ming-hua Cao
Yong-yu Li
Jing Xu
Ya-jing Feng
Xu-hong Lin
Kun Li
Tong Han
Chang-jie Chen
author_sort Ming-hua Cao
title Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
title_short Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
title_full Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
title_fullStr Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
title_full_unstemmed Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
title_sort cannabinoid hu210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Acute pancreatitis (AP), especially severe acute pancreatitis often causes extra-pancreatic complications, such as acute gastrointestinal mucosal lesion (AGML) which is accompanied by a considerably high mortality, yet the pathogenesis of AP-induced AGML is still not fully understood. In this report, we investigated the alterations of serum components and gastric endocrine and exocrine functions in rats with experimental acute pancreatitis, and studied the possible contributions of these alterations in the pathogenesis of AGML. In addition, we explored the intervention effects of cannabinoid receptor agonist HU210 and antagonist AM251 on isolated and serum-perfused rat stomach. Our results showed that the AGML occurred after 5 h of AP replication, and the body homeostasis was disturbed in AP rat, with increased levels of pancreatic enzymes, lipopolysaccharide (LPS), proinflammtory cytokines and chemokines in the blood, and an imbalance of the gastric secretion function. Perfusing the isolated rat stomach with the AP rat serum caused morphological changes in the stomach, accompanied with a significant increment of pepsin and [H+] release, and increased gastrin and decreased somatostatin secretion. HU210 reversed the AP-serum-induced rat pathological alterations, including the reversal of transformation of the gastric morphology to certain degree. The results from this study prove that the inflammatory responses and the imbalance of the gastric secretion during the development of AP are responsible for the pathogenesis of AGML, and suggest the therapeutic potential of HU210 for AGML associated with acute pancreatitis.
url http://europepmc.org/articles/PMC3532296?pdf=render
work_keys_str_mv AT minghuacao cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
AT yongyuli cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
AT jingxu cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
AT yajingfeng cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
AT xuhonglin cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
AT kunli cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
AT tonghan cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
AT changjiechen cannabinoidhu210protectsisolatedratstomachagainstimpairmentcausedbyserumofratswithexperimentalacutepancreatitis
_version_ 1725910935023910912